As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

The latter is very important for Novartis as a number of pharma companies are trying to find drugs to treat this ... aid during cold snap The UK tele-pharmacy app, Now Patient, experienced ...

Drugmakers raised the list prices of more than 800 prescription ... to Novartis and Bristol-Myers Squibb, according to an analysis for The Wall Street Journal by 46brooklyn, a nonprofit drug ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

RxTechExam and the Pennsylvania Pharmacists Association announced a strategic partnership. Roche’s $8 billion InterMune acquisition has been handed to a specialty pharmaceutical company, Cayman ...